dc.contributor.advisor | Eghdamzamiri, Reza | |
dc.contributor.author | Khalafi, Mohammad | |
dc.date.accessioned | 2021-09-11T09:30:38Z | |
dc.date.available | 2021-09-11T09:30:38Z | |
dc.date.issued | 2021 | en_US |
dc.identifier.uri | http://dspace.tbzmed.ac.ir:8080/xmlui/handle/123456789/65089 | |
dc.description.abstract | Today Radiotherapy and Chemotherapy acting a major role in treatment of Malignancies. The importance of Radiotherapy in Pelvic Solid Tumours (PST) is undeniable. Chemoradiation for PST use as Adjvant or Neoadjvant therapy.
Methods: In this cohort study 51 patient who was treated by Chemoradiation because of PST followed for a week. We used their Body temperature (BT) and the changes of their Neutrophils count after treatment. Study Data’s accumulated by patient's weekly Complete Blood Count Diff (CBC diff).
Results: In this study, after analysing the obtained data, it was observed that only 10 patients with fever (19.6%) and 13 patients with neutropenia (25.5%), Only 3 patients (5.8%) had concomitant fever and neutropenia. In other words, changes in body temperature following radiotherapy were not significant, while changes in neutrophil count, lymphocytes and platelets were significant. | en_US |
dc.language.iso | fa | en_US |
dc.publisher | Tabriz University of Medical Sciences, Faculty of Medicine | en_US |
dc.subject | Pelvic Solid Tumours | en_US |
dc.subject | Febrile and Neutropenia | en_US |
dc.subject | Radiotherapy | en_US |
dc.subject | Chemotherapy | en_US |
dc.title | Frequency of fever and neutropenia in patients undergoing pelvic Radiotherapy | en_US |
dc.type | Thesis | en_US |
dc.contributor.supervisor | Taghizadeh, Sepehr | |
dc.identifier.docno | 6010054 | en_US |
dc.identifier.callno | 10054 | en_US |
dc.description.discipline | Medicine | en_US |
dc.description.degree | MD Degree | en_US |